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Summary.-A simple, rapid histone agglutination test (HAT) is described. It
consists of incubation in microplates or in microtubes of blood lymphocytes isolated
from cancer patients and patients with non-malignant diseases with microquantities
of histone fraction F2AL. Positive reaction is shown by massive agglutination of
lymphocytes of the patients tested (126 subjects): this test was positive in 76% of
cases. All controls (59 subjects) were negative.
IN 1970 Field and Caspary reported
that the incubation of peripheral blood
lymphocytes from cancer patients with
basic protein of myelin in the presence
of guinea-pig macrophages lowered the
electrophoretic mobility of the macro-
phages. This test was called the MEM
(macrophage electrophoretic mobility) test
and was confirmed by Pritchard et al.
in 1972.
Acid extracts of tumours were found
to be a more effective antigen in this test
(Caspary and Field, 1971; Carnegie, Cas-
pary and Field, 1973) and in 1973 Johns
et al. reported that histone fractions
isolated from calf thymus gave a positive
reaction in the MEM test.
These results prompted us to see
whether the reaction of lymphocytes with
histone fraction could be measured di-
rectly, i.e. if incubation of lymphocytes
from cancer patients with histone fractions
changes their electrophoretic mobilities.
Moreover, we wished to determine which
population of blood lymphocytes (T and
B) as detected by electrophoretic analysis
(Sabolovic, Sabolovic' and Dumont, 1972)
reacts with the histone in the test.
The first patients studied (3 acute
lymphocytic leukaemias, one chronic lym-
phocytic leukaemia and 5 solid tumours)
showed a complete loss of cell surface
charge of all their lymphocytes after
10 min incubation with histone, and the
measurement of electrophoretic mobilities
was quite impossible. Control lympho-
cytes were not affected.
This positive reaction was accom-
panied by a discrete microagglutination
of the lymphocytes which was maximal
after 30 min incubation, and this criterion
is now used by us routinely to test the
positive reactions. In this paper we
report a preliminary observation on 126
patients with malignant and non-malig-
nant diseases and 59 healthy controls
using histone agglutination test (HAT).
MATERIALS AND METHODS
Lymphocytes were isolated by Ficoll-
Isopaque mixture as described previously
(Sabolovi6 et al., 1974). About 5 ml of
blood were sufficient to do this test. The
lymphocyte suspension must be as pure as
possible; if platelet, monocyte and granulo-
cyte contamination are high then washing
with Medium 199 and keeping the cells at
room temperature for an hour promote the
aggregation of platelets and the attachment
of the monocytes and granulocytes to the
glass. In the first series of experiments
the test was done in microplates and results
were evaluated microscopically. II theAGOGLUTINATION OF PERIPHERAL BLOOD LYMPHOCYTES
Histone agglutination test in microtubes. Five min reaction. x 4.
second series the test was done in microtubes
(41 x 8 mm) and evaluated macroscopically.
Both techniques gave the same results.
Test in "microtest plates '.-Lympho-
cytes were washed with Hanks' medium, and
diluted with Hanks' medium at concentra-
tions of 3000 lymphocytes/mm3. Histone
fractions (gift of Dr Johns, Chester Beatty
Institute) were dissolved in 0-145 mol/l
NaCl. Serial dilutions of histone (starting
with 10 jtg in 25 ,ul in the first well) were
then mixed with equal volumes of lympho-
cytes (i.e. 75,000 lymphocytes in 25 ul
per well). The plates were incubated for
30 min at 37°C and examined under the
microscope.
Test in microtubes.-Lymphocytes were
washed again with PBS and suspended in
PBS at a concentration of 3000 lympho-
cytes/mm3. 0-25 ml of this suspension was
distributed in microtubes (41 x 8 mm) and
20 ,tg of histone fraction was added to the
test tube. The reaction was read after
5 min and verified again after 30 min,
without incubation at 37°C. Where there
was a positive reaction the agglutination
of lymphocytes was clearly visible (see
Figure).
For electrophoretic mobility analysis,
the incubation at room temperature was
stopped after 5 min and cells were washed
with 0-145 mol/l NaCI, pH 7-2, and measured
in cylindrical electrophoresis apparatus as
described (Sabolovic et al., 1974).
RESULTS
Patients with various tumours were
tested, together with patients with a
variety of other diseases. They included
patients without treatment as well as
those under treatment. Moreover, some
ofthe patients were followed up for a 5-10
month period and retested at irregular
intervals. The controls included normal
subjects ofboth sexes and all ages, normal
thymus cells and tonsil lymphocytes.
Table I shows the results obtained
with all patients tested and Table II
shows the evolution of sensitivity to
agglutination in 3 individual patients.
All 5 fractions of histones (Fl, F2A1,
F2A2, F2B and F3) were tested but
positive reactions were observed only
with F2A1 and sometimes with F2A1,
F2B and F3 (Table I). 76% of all
patients were positive in our test com-
pared with negative reactions in 59
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TABLE I.-Histone Agglutination Test on Cancer Patients, Patients withNon-malignant
Diseases and Healthy Controls
Peripheral lymphocytes
from patients with
Cancer of ORL
Cancer of the lip
Cancer of breast
Cancer of bladder
Cancer of the prostate
Retroperitoneal sarcoma
Cancer of cervix
Carcinoma of the colon
CLL
ALL (children)
ALL (adults)
Hodgkin's disease
Thymoma
Lymphoblastosarcoma
Leukaemic lymphoblastosarcoma
Sarcoma of the uterus
Carcinoma (non-differentiated)
Sezarie's disease
Lupus erythematosus
Rheumatoid arthritis
Connective tissue disease
Sciatica
Rheumatic gout
Chronic arthrosis
Coombs positive patient
Graft-versus-host disease
Asthma
Normal tonsil
Normal thymus cells
Healthy controls
Positive with
F2A1
±
+
+
±
+
+
±
+
F2B
NT
Nr
NT
Nr
NT
NT
±
+
+
NT
NT
NT
NT
NT
NT
NT
NT
NT
NT
NT
F3
NT
NT
NT
Nr
NT
NT
+
+
NT
NT
NT
NT
NT
NT
NT
NT
NT
NT
NT
No. of patients tested
Positive Negative Total
7 2 (4)4 13
1 1
49 8 (2)t 59
1 1
2 2
1 1
2 2
2 2
6 4 10
6 I 7
2 2
3 3
2 2
2 2
1 1
1 1
1 1
1 1
2 2
7 1 8
1 1
1 1
1 1
1 1.
1 1
1 1
1 1
1 1
2 2
59 59
NT = not tested; * died on the same day; t benign tumours of the breast; t irradiated.
Agglutination with histone fractions was performed in microplates or in tubes. Equal concentrations
of lymphocytes (3000/mm3) were mixed with histone fractions and the reaction was scored after 30 min
of incubation at room temperature (see text).
TABLE II.-Histone Agglutination Test on IndividualPatients
Patient
G.D. (18 years old)
Acute lymphocytic leukaemia in
remission
R.A. (14 years old)
Acute lymphocytic leukaemia with
circulating lymphoblasts
Date
22.1.74
5.2.74
12.3.74
7.10.74
15.2.75
21.1.74
22.1.74
25.1.74
18.2.74
12.3.74
13.5.74
Died
Active
fraction
F2A1
F2A1
F2A1
F2A1
F2A1
F2A1
F2A1
F2A1
F2A1
F2A1
F2A1
F2B
F3
Dilution ofhistone
10 ug 2 5 ,ug 12 25,ug 0 624ug 0 31 ,g
+
± + + +
+ + +
+ + + + +
+ +
+
+
+ ±
+
+
+
+ +
B.L.
Cancer of breast
29.1.74 F2A1 +
8.2.74 F2A1 +
14.2.74 F2A1 +
L.P.S. 8.2.74
Cancer ofbreast. Irradiation started 14.2.74
F2A1 +
F2A1 + + + +
Histone agglutination test was performed in microtest plates as described in the text.
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healthy controls. In the breast cancer
group, for instance, positive reactions
were observed in 86% of cases.
Not all patients were positive for a
given group but it must be noted that
some of the patients were in an advanced
stage of the disease: one patient with
acute lymphocytic leukaemia who was
negative in HAT died on the same day
and one woman with cancer of the
breast, negative in HAT, had a multiple
metastasis, 4 patients with cancer of
ORL received local body irradiation and
were negative in the test.
Benign tumours of the breast, chronic
arthrosis, Sezarie's disease, cancer of the
prostate and acute lymphocytic leukaemia
in adults and lymphoblastosarcoma were
all negative in the HAT.
Two patients with acute lymphocytic
leukaemia (children) and 2 patients with
cancer of the breast were followed up
and retested at different periods of the
disease (Table II). It can be seen that
the sensitivity to histone agglutination
changes during the evolution of the
disease: patient R.A. became positive
to the fraction F3 just before death;
patient L.P.S. had an increased positivity
after irradiation.
Poly-L-arginine (Biochemicals) and
poly-L-lysine were tested and found to
be negative even at doses of 50 1ag/75,000
lymphocytes. Positive reactions were ob-
tained with Poly-L-arginine (Sigma) in
the 2 cases tested. Incubation of HAT-
positive lymphocytes with PPD antigen
or with sheep red cells for 15 min did
not provoke agglutination and did not
change their electrophoretic mobilities
either.
When the reaction with the histone
fraction was very strong, all cells were
agglutinated and measurement of electro-
phoretic mobilities was impossible, but
if the cell concentration was diluted
six-fold and histone fraction added, no
agglutination occurred at all, and then
an electrophoretic analysis became pos-
sible: all lymphocytes were immobilized
in the electric field and even became
3
charged positively, i.e. moved in the
opposite direction. These experiments
also demonstrate the importance of lym-
phocyte concentration per mm3 in order
to assure agglutination in the positive
cases.
DISCUSSION
The macrophage electrophoretic mo-
bility test (MEM) devised by Field and
Caspary (1970) measures the lymphocyte-
histone interaction indirectly, i.e. a soluble
principle released by this interaction
retards the electrophoretic mobilities of
guinea-pig macrophages (Johns et al.,
1973).
Our results show that the histone-
lymphocyte interaction can be measured
directly using electrophoretic mobility
of lymphocytes or using the histone
agglutination test (HAT) which is in
contrast very simple. The agglutination
of the peripheral lymphocytes with F2A1
histone fraction and loss of cell surface
charge (or reversal of this charge from
negative to the positive one) takes a
few seconds or minutes, suggesting an
immediate reaction on the cell surface
between sensitized lymphocytes and his-
tone protein.
Lymphocytes from 59 normal, healthy
individuals do not react in this test but
76% (128 cases) of patients with malig-
nant and non-malignant diseases possess
reactive lymphocytes in the circulation.
It is not excluded that lymphocytes in
normal individuals are completely devoid
of " receptors " for F2Al histone fraction
but the number of these lymphocytes
or concentration of such a ' receptors
must be very feeble.
We focused our attention at first
on the study of cancer patients and
later we found that non-cancerous diseases
also react and for this reason the HAT
cannot be considered as specific for cancer.
Using the MEM test, Field and
Caspary (1972; Field, Caspary and Smith,
1973) stated that any patient with
neurological or viral disease was un-
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suitable for cancer testing in the MEM
and also found that some inflammatory,
non-malignant diseases gave a positive
reaction.
What is the meaning of the lympho-
cyte-histone interaction? Caspary and
Field (1971) and Dickinson and Caspary
(1973) supported the idea that peripheral
lymphocytes become sensitized to a com-
mon tumour antigen present in tumour
tissue and also in all myelinated nervous
tissue. Structurally related basic cancer
protein, encephalitogenic protein to F2AL
histone fraction, might explain the antigen
cross reactivity in the MEM test. Our
interpretation follows the idea that during
any pathological process (cancerous or
not) involving reaction of the immune
system, lymphocytes become sensitized
to the self-antigens in parallel. For
instance, the virus may be responsible
for this deviation of immune reaction
(Allison et al., 1971). It is relevant to
this that one Coombs' positive patient
and one patient grafted with lymphoid
cells and undergoing the graft-versus-host
reaction were positive in the HAT.
Our test discriminates between benign
and malignant tumours of the breast;
the former were negative in the HAT.
Negative results were observed in some
patients in the ORL group treated with
irradiation and in some patients in an
advanced stage of the disease, as has
also been reported by Field et al. (1973)
for the MEM test. In contrast to the
MEM test, we obtained positive reactions
in acute lymphocytic leukaemia during
relapse or remission in children and in
most chronic lymphocytic leukaemia. Our
findings also corroborate a recent study
of Fish, Pritchard and Deeley (1974) who
showed that the incubation of lynipho-
cytes from cancer patients with F2A1
histone fraction for 90 min induces the
appearance in the supernatant fluid of
a component of molecular weight smaller
than the original histone F2A1 fraction.
They suggested that F2A1 fraction is
degraded by the proteolytic action of
lymphocytes from cancer patients. These
experiments also indicate that an active
interaction between cancer lymphocytes
and F2A1 histone fraction does take
place, but these authors had not tested
any of the patients with non-malignant
diseases.
It is clear that much work must be
done in order to elucidate the mechanism
of the histone-lymphocyte reaction in
vitro as well as the pathway of the in
vivo sensitization, and to determine
whether the F2A1 reaction could be
useful in the early detection of patho-
logical process in the organism, and also
its relationship with the immunological
system. For this purpose, the histone
agglutination test (HAT) we have de-
scribed is simple, rapid and requires a
minimum of laboratory practice.
This work was supported by INSERM
(ATP No. 16) and by Fondation pour
la Recherche Medicale Frang,aise. We
are indebted to Professor J. L. Amiel
and Dr J. Rouesse who allowed us to
study most of the patients described
here.
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